Loading clinical trials...
Loading clinical trials...
A PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT
Conditions
Interventions
Investigational Medical Product (IMP) administered in parent study
Locations
79
United States
Central Alabama Research
Birmingham, Alabama, United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Alabama Orthopaedic Surgeons
Birmingham, Alabama, United States
Cahaba Research Inc.
Birmingham, Alabama, United States
Noble Clinical Research
Tucson, Arizona, United States
Baptist Health Center for Clinical Research
Little Rock, Arkansas, United States
Start Date
August 23, 2016
Primary Completion Date
July 15, 2019
Completion Date
July 15, 2019
Last Updated
July 30, 2020
NCT07153471
NCT07351968
NCT06747494
NCT06381791
NCT07327931
NCT06906939
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions